Management of patients with uncontrolled arterial hypertension - The role of electronic compliance monitoring, 24-h ambulatory blood pressure monitoring and Candesartan/HCT

BMC Cardiovascular Disorders

Volumn 6, Issue , 2006, Pages

  Mengden, Thomas ^a   Vetter, Hans ^a   Tousset, Eric ^b   Uen, Sakir ^a  

^a UNIVERSITY OF BONN   (Germany)

^b AARDEX Ltd   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL OBSERVATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG SUBSTITUTION; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONITOR; OSCILLOMETRY; PATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; SELF MONITORING; SYSTOLIC BLOOD PRESSURE;

AGED; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; DRUG MONITORING; DRUG THERAPY, COMBINATION; ELECTRONICS, MEDICAL; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; OFFICE VISITS; PATIENT COMPLIANCE; TETRAZOLES;

EID: 33749540898     PISSN: 14712261     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-6-36     Document Type: Article

References (17)

1. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD: Persistence with treatment for hypertension in actual practice. Canad Med Assoc J 1999, 160(1):31-7.
2. Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD: Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. Canad Med Assoc J 1999, 160(1):41-6.
3. Lacourciere Y, Asmar R: A comparison of the efficacy and duration of action of candesartan Cilexetil and Losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/ Losartan study investigators. Am J Hypertens 1999, 12(12 Pt 1-2):1181-7.
4. Stephenson J: Noncompliance may cause half of antihypertensive drug "failures". Interview with Prof. H-R Brunner. JAMA 1999, 282(4):313-4.
5. Mengden T, Chamontin B, Phong Chau N, Luis Palma Gamiz J, Chanudet X: User procedure for self-measurement of blood pressure. First International Consensus Conference on Self Blood Pressure Measurement. Blood Press Monit 2000, 5(2):111-29.
6. Barna I, Keszei A, Dunai A: Evaluation of Meditech ABPM-04 ambulatory blood pressure measuring device according to the British Hypertension Society protocol. Blood Press Monit 1998, 3(6):363-8.
7. Rogoza AN, Pavlova TS, Sergeeva MV: Validation of the A&D UA767 device for the self-measurement of blood pressure. Blood Press Monit 2000, 5(4):227-31.
8. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual LM, Ruilope LM: Prognostic Value of Ambulatory Blood Pressure Monitoring in Refractory Hypertension: A Prospective Study. Hypertension 1998, 31(2):712-8.
9. Vrijens B, Goetghebeur E: Comparing compliance patterns between randomized treatments. Control Clin Trials 1997, 18(3):187-203.
10. Mallion JM, Dutrey-Dupagne C, Vaur L, Genes N, Renault M, Elkik F, Baguet P, Boutelant S: Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. J Hypertens 1996, 14(1):137-44.
11. Johnson BF, Whelton A: A study design for comparing the effects of missing daily doses of antihypertensive drugs. Am J Ther 1994, 1(4):260-7.
12. Vaur L, Dutrey-Dupagne C, Boussac J, Genes N, Bouvier d'Yvoire M, Elkik F, Meredith PA: Differential effects of a missed dose of trandolapril and enalapril on blood pressure control in hypertensive patients. J Cardiovasc Pharmacol. 1995, 26(1):127-31.
13. Leenen FH, Fourney A, Notman G, Tanner J: Persistence of antihypertensive effect after 'missed doses' of calcium antagonist with long (amlodipine) vs short (diltiazem) elimination half-life. Br J Clin Pharmacol 1996, 41(2):83-8.
14. Hernandez-Hernandez R, Armas de Hernandez MJ, Armas-Padilla MC, Carvajal AR, Guerrero-Pajuelo J: The effects of missing a dose of enalapril versus amlodipine on ambulatory blood pressure. Blood Press Monit 1996, 1(2):121-6.
15. Burnier M, Schneider MP, Chiolero A, Stubi CL, Brunner HP: Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 2001, 19(2):335-41.
16. Cramer JA: Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 1995, 49(3):321-7.
17. Kruse W, Rampmaier J, Ullrich G, Weber E: Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care. Int J Clin Pharmacol Ther 1994, 32(9):452-7.